Back to Browse Journals » Hypoxia » Volume 1

Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein

Authors Place TL, Domann FE

Published Date October 2013 Volume 2013:1 Pages 13—27

DOI http://dx.doi.org/10.2147/HP.S50091

Received 18 June 2013, Accepted 1 August 2013, Published 16 October 2013

Trenton L Place,1 Frederick E Domann1,2

1Molecular and Cellular Biology Program, the University of Iowa, Iowa City, IA, USA; 2Department of Radiation Oncology, the University of Iowa, Iowa City, IA, USA

Abstract: The ability of cells to sense oxygen is a highly evolved process that facilitates adaptations to the local oxygen environment and is critical to energy homeostasis. In vertebrates, this process is largely controlled by three intracellular prolyl-4-hydroxylases (PHD) 1–3. These related enzymes share the ability to hydroxylate the hypoxia-inducible transcription factor (HIF), and therefore control the transcription of genes involved in metabolism and vascular recruitment. However, it is becoming increasingly apparent that PHD controls much more than HIF signaling, with PHD3 emerging as an exceptionally unique and functionally diverse PHD isoform. In fact, PHD3-mediated hydroxylation has recently been purported to function in such diverse roles as sympathetic neuronal and muscle development, sepsis, glycolytic metabolism, and cell fate. PHD3 expression is also highly distinct from that of the other PHD enzymes, and varies considerably between different cell types and oxygen concentrations. This review will examine the evolution of oxygen sensing by the HIF family of PHD enzymes, with a specific focus on the complex nature of PHD3 expression and function in mammalian cells.

Keywords: PHD3, EGLN3, HIF–PHD, hypoxia-inducible factor, hypoxia, oxygen sensing

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies

Wang Z, Mu HJ, Zhang XM, Ma PK, Lian SN, Zhang FP, Chu SY, Zhang WW, Wang AP, Wang WY, Sun KX

International Journal of Nanomedicine 2015, 10:633-644

Published Date: 14 January 2015

Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models

Stevenson JM, Williams JL, Burnham TG, Prevost AT, Schiff R, Erskine SD, Davies JG

Clinical Interventions in Aging 2014, 9:1581-1593

Published Date: 19 September 2014

Polyhydroxylated fullerene attenuates oxidative stress-induced apoptosis via a fortifying Nrf2-regulated cellular antioxidant defence system

Ye SF, Chen M, Jiang YQ, Chen ML, Zhou T, Wang YG, Hou ZQ, Ren L

International Journal of Nanomedicine 2014, 9:2073-2087

Published Date: 29 April 2014

Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid)

Chen Y, Yang Z, Liu C, Wang C, Zhao S, Yang J, Sun H, Zhang Z, Kong D, Song C

International Journal of Nanomedicine 2013, 8:4315-4326

Published Date: 7 November 2013

Hypoxia attenuates purinergic P2X receptor-induced inflammatory gene expression in brainstem microglia

Smith SMC, Mitchell GS, Friedle SA, Sibigtroth CM, Vinit S, Watters JJ

Hypoxia 2013, 1:1-11

Published Date: 6 August 2013

Subluxed traumatic cataract: optical coherence tomography findings and clinical management

Kuriyan AE, Flynn Jr HW, Yoo SH

Clinical Ophthalmology 2012, 6:1997-1999

Published Date: 4 December 2012

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications

Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O

International Journal of Nanomedicine 2012, 7:1841-1850

Published Date: 11 April 2012

Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy

Wu X, Ding B, Gao J, Wang H, Fan W, Wang X, Zhang W, Wang X, Ye L, Zhang M, Ding X, Liu J, Zhu Q, Gao S

International Journal of Nanomedicine 2011, 6:1747-1756

Published Date: 19 August 2011

Recent advances in PEG–PLA block copolymer nanoparticles

Ren Zhong Xiao, Zhao Wu Zeng, Guang Lin Zhou, et al

International Journal of Nanomedicine 2010, 5:1057-1065

Published Date: 26 November 2010